- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/40 - Cyclodextrins; Derivatives thereof
Patent holdings for IPC class A61K 47/40
Total number of patents in this class: 1836
10-year publication summary
|
115
|
90
|
146
|
165
|
213
|
224
|
236
|
179
|
171
|
53
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Axsome Therapeutics, Inc. | 213 |
85 |
| CyDex Pharmaceuticals, Inc. | 108 |
54 |
| Novartis AG | 11238 |
18 |
| Massachusetts Institute of Technology | 9795 |
17 |
| Pfizer Inc. | 3322 |
16 |
| The Brigham and Women's Hospital, Inc. | 2087 |
16 |
| The Regents of the University of California | 18943 |
15 |
| Aldeyra Therapeutics, Inc. | 100 |
14 |
| Allergan, Inc. | 2600 |
13 |
| Altergon S.A. | 145 |
13 |
| Cardioxyl Pharmaceuticals, Inc. | 49 |
11 |
| Yale University | 2204 |
11 |
| Roquette Freres | 1002 |
10 |
| Sapiotec GmbH | 25 |
10 |
| Boehringer Ingelheim Vetmedica GmbH | 1290 |
9 |
| Ono Pharmaceutical Co., Ltd. | 454 |
9 |
| MEI Pharma, Inc. | 80 |
8 |
| Nanjing Normal University | 66 |
8 |
| Oculis Operations Sàrl | 23 |
8 |
| Lenz Therapeutics Operations, Inc. | 31 |
8 |
| Other owners | 1483 |